UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.735

Sortiert nach

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary

Clinical infectious diseases, 2011-02, Vol.52 (3), p.285-292

2011

Volltextzugriff (PDF)

The Pharmacokinetic and Pharmacodynamic Properties of Vancomycin

Clinical infectious diseases, 2006-01, Vol.42 (Supplement-1), p.S35-S39

Rybak, Michael J

2006

Volltextzugriff (PDF)

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

Clinical infectious diseases, 2011-02, Vol.52 (3), p.e18-e55

2011

Volltextzugriff (PDF)

A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity

Antimicrobial agents and chemotherapy, 2017-12, Vol.61 (12)

2017

Volltextzugriff (PDF)

A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis

Clinical infectious diseases, 2018-07, Vol.67 (2), p.303-309

2018

Volltextzugriff (PDF)

Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Clinical infectious diseases, 2020-09, Vol.71 (6), p.1361-1364

2020

Volltextzugriff (PDF)

Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin

Antimicrobial agents and chemotherapy, 2018-01, Vol.62 (1)

2018

Volltextzugriff (PDF)

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists

Clinical infectious diseases, 2009-08, Vol.49 (3), p.325-327

2009

Volltextzugriff (PDF)

Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets

Clinical infectious diseases, 2011-04, Vol.52 (8), p.975-981

2011

Volltextzugriff (PDF)

Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin–Tazobactam Compared to Those on Vancomycin and Cefepime

Clinical infectious diseases, 2017-01, Vol.64 (2), p.116-123

2017

Volltextzugriff (PDF)

Catalytic Synthesis of Conjugated Azopolymers from Aromatic Diazides

Journal of the American Chemical Society, 2021-03, Vol.143 (10), p.3975-3982

2021

Volltextzugriff (PDF)

Application of natural and semi-synthetic polymers for the delivery of sensitive drugs

International materials reviews, 2015-02, Vol.60 (2), p.101-131

2015

Volltextzugriff (PDF)

Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model

Antimicrobial Agents and Chemotherapy, 2013-01, Vol.57 (1), p.66-73

2013

Volltextzugriff (PDF)

Impact of High-Inoculum Staphylococcus aureus on the Activities of Nafcillin, Vancomycin, Linezolid, and Daptomycin, Alone and in Combination with Gentamicin, in an In Vitro Pharmacodynamic Model

Antimicrobial Agents and Chemotherapy, 2004-12, Vol.48 (12), p.4665-4672

2004

Volltextzugriff (PDF)

A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis

Journal of antimicrobial chemotherapy, 2013-12, Vol.68 (12), p.2921-2926

2013

Volltextzugriff (PDF)

Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin‐Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health‐System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Pharmacotherapy, 2020-04, Vol.40 (4), p.363-367

2020

Volltextzugriff (PDF)

Activities of High-Dose Daptomycin, Vancomycin, and Moxifloxacin Alone or in Combination with Clarithromycin or Rifampin in a Novel In Vitro Model of Staphylococcus aureus Biofilm

Antimicrobial Agents and Chemotherapy, 2010-10, Vol.54 (10), p.4329-4334

2010

Volltextzugriff (PDF)

Novel Combinations of Vancomycin plus Ceftaroline or Oxacillin against Methicillin-Resistant Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA

Antimicrobial Agents and Chemotherapy, 2013-05, Vol.57 (5), p.2376-2379

2013

Volltextzugriff (PDF)

Current and prospective treatments for multidrug-resistant gram-positive infections

Expert opinion on pharmacotherapy, 2013-10, Vol.14 (14), p.1919-1932

2013

Volltextzugriff (PDF)

Outcomes Analysis of Delayed Antibiotic Treatment for Hospital-Acquired Staphylococcus aureus Bacteremia

Clinical infectious diseases, 2003-06, Vol.36 (11), p.1418-1423

2003

Volltextzugriff (PDF)

Spectroscopic Inversions of the Ca ii 8542 Line in a C-class Solar Flare

The Astrophysical journal, 2017-09, Vol.846 (1), p.9

2017

Volltextzugriff (PDF)

The combination of ceftaroline plus daptomycin allows for therapeutic de-escalation and daptomycin sparing against MRSA

Journal of antimicrobial chemotherapy, 2015-02, Vol.70 (2), p.505-509

2015

Volltextzugriff (PDF)

Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia

Journal of antimicrobial chemotherapy, 2015-01, Vol.70 (1), p.311-313

2015

Volltextzugriff (PDF)

Daptomycin: The role of high-dose and combination therapy for Gram-positive infections

International journal of antimicrobial agents, 2013-09, Vol.42 (3), p.202-210

2013

Volltextzugriff (PDF)

The β-Lactams Strike Back: Ceftazidime-Avibactam

Pharmacotherapy, 2015-08, Vol.35 (8), p.755-770

2015

Volltextzugriff (PDF)

1 – 25 von 1.735

Suche als RSS-Feed

Aktive Filter

SpracheDeutsch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.513)
Mit Volltextzugriff
(1.467)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.541)
Japanisch
(146)
Französisch
(122)
Polnisch
(39)
Tschechisch
(20)
Spanisch
(10)
Russisch
(6)

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.002)
Life Sciences & Biomedicine
(787)
Humans
(599)
Pharmacology & Pharmacy
(335)
Biological And Medical Sciences
(331)
Medical Sciences
(290)
Microbiology
(281)
Female
(243)
Male
(235)
Animals
(228)
Pharmacology. Drug Treatments
(220)
Infectious Diseases
(216)
Microbial Sensitivity Tests
(198)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(176)
Physical Sciences
(174)
Anti-Bacterial Agents - Pharmacology
(161)
Staphylococcus Aureus
(154)
Adult
(148)
Middle Aged
(138)
Antibacterial Agents
(119)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(105)

Menü

Weitere Dienste

Einstellungen

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary

The Pharmacokinetic and Pharmacodynamic Properties of Vancomycin

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity

A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis

Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists

Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets

Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin–Tazobactam Compared to Those on Vancomycin and Cefepime

Catalytic Synthesis of Conjugated Azopolymers from Aromatic Diazides

Application of natural and semi-synthetic polymers for the delivery of sensitive drugs

Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model

Impact of High-Inoculum Staphylococcus aureus on the Activities of Nafcillin, Vancomycin, Linezolid, and Daptomycin, Alone and in Combination with Gentamicin, in an In Vitro Pharmacodynamic Model

A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis

Activities of High-Dose Daptomycin, Vancomycin, and Moxifloxacin Alone or in Combination with Clarithromycin or Rifampin in a Novel In Vitro Model of Staphylococcus aureus Biofilm

Novel Combinations of Vancomycin plus Ceftaroline or Oxacillin against Methicillin-Resistant Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA

Current and prospective treatments for multidrug-resistant gram-positive infections

Outcomes Analysis of Delayed Antibiotic Treatment for Hospital-Acquired Staphylococcus aureus Bacteremia

Spectroscopic Inversions of the Ca ii 8542 Line in a C-class Solar Flare

The combination of ceftaroline plus daptomycin allows for therapeutic de-escalation and daptomycin sparing against MRSA

Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia

Daptomycin: The role of high-dose and combination therapy for Gram-positive infections

The β-Lactams Strike Back: Ceftazidime-Avibactam

Aktive Filter

Suchergebnisse filtern